Candidate susceptibility variants for esophageal squamous cell carcinoma. 2017

Iikki Donner, and Riku Katainen, and Tomas Tanskanen, and Eevi Kaasinen, and Mervi Aavikko, and Kristian Ovaska, and Miia Artama, and Eero Pukkala, and Lauri A Aaltonen
Department of Medical and Clinical Genetics, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Esophageal cancer is common worldwide, and often fatal. The major histological subtype is esophageal squamous cell carcinoma (ESCC). ESCC shows familial aggregation and high heritability. Mutations in RHBDF2 cause tylosis, a very rare disorder characterized by high life-time risk of ESCC, but no other well-established predisposition genes have been identified. To identify candidate susceptibility variants for ESCC we utilized the Population Information System and the Finnish cancer registry to find study materials by clustering ESCC patients by family name at birth and municipality at birth. We collected archival tissue material and exome sequenced a total of 30 ESCC cases. We prioritized shared, deleterious and rare variants that were significantly enriched in our sample set compared to Finnish and population subset specific controls. Six variants passed filtering, the most frequent being a nonsense mutation in DNAH9 (p.Tyr1573Ter) found in four unrelated patients. DNAH9 has been reported to be frequently lost in ESCC tumors. In this study, one patient's tumor showed loss of the wild type allele of DNAH9 suggesting a tumor suppressive function. A missense variant in GKAP1 was shared by three patients, and missense variants in BAG1, NFX1, FUK, and DDOST by two each. EP300 which has previously been implicated in the genesis of ESCC had a missense variant segregating in three affected individuals in a single family. If validated in independent patient sets, these variants could serve as a tool towards prevention and early diagnosis of ESCC.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D004938 Esophageal Neoplasms Tumors or cancer of the ESOPHAGUS. Cancer of Esophagus,Esophageal Cancer,Cancer of the Esophagus,Esophagus Cancer,Esophagus Neoplasm,Neoplasms, Esophageal,Cancer, Esophageal,Cancer, Esophagus,Cancers, Esophageal,Cancers, Esophagus,Esophageal Cancers,Esophageal Neoplasm,Esophagus Cancers,Esophagus Neoplasms,Neoplasm, Esophageal,Neoplasm, Esophagus,Neoplasms, Esophagus
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Iikki Donner, and Riku Katainen, and Tomas Tanskanen, and Eevi Kaasinen, and Mervi Aavikko, and Kristian Ovaska, and Miia Artama, and Eero Pukkala, and Lauri A Aaltonen
March 2011, Carcinogenesis,
Iikki Donner, and Riku Katainen, and Tomas Tanskanen, and Eevi Kaasinen, and Mervi Aavikko, and Kristian Ovaska, and Miia Artama, and Eero Pukkala, and Lauri A Aaltonen
July 2015, Scientific reports,
Iikki Donner, and Riku Katainen, and Tomas Tanskanen, and Eevi Kaasinen, and Mervi Aavikko, and Kristian Ovaska, and Miia Artama, and Eero Pukkala, and Lauri A Aaltonen
February 2009, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego,
Iikki Donner, and Riku Katainen, and Tomas Tanskanen, and Eevi Kaasinen, and Mervi Aavikko, and Kristian Ovaska, and Miia Artama, and Eero Pukkala, and Lauri A Aaltonen
September 2015, Scientific reports,
Iikki Donner, and Riku Katainen, and Tomas Tanskanen, and Eevi Kaasinen, and Mervi Aavikko, and Kristian Ovaska, and Miia Artama, and Eero Pukkala, and Lauri A Aaltonen
January 2012, Asian Pacific journal of cancer prevention : APJCP,
Iikki Donner, and Riku Katainen, and Tomas Tanskanen, and Eevi Kaasinen, and Mervi Aavikko, and Kristian Ovaska, and Miia Artama, and Eero Pukkala, and Lauri A Aaltonen
January 2020, Methods in molecular biology (Clifton, N.J.),
Iikki Donner, and Riku Katainen, and Tomas Tanskanen, and Eevi Kaasinen, and Mervi Aavikko, and Kristian Ovaska, and Miia Artama, and Eero Pukkala, and Lauri A Aaltonen
May 2017, Current oncology reports,
Iikki Donner, and Riku Katainen, and Tomas Tanskanen, and Eevi Kaasinen, and Mervi Aavikko, and Kristian Ovaska, and Miia Artama, and Eero Pukkala, and Lauri A Aaltonen
June 2010, Carcinogenesis,
Iikki Donner, and Riku Katainen, and Tomas Tanskanen, and Eevi Kaasinen, and Mervi Aavikko, and Kristian Ovaska, and Miia Artama, and Eero Pukkala, and Lauri A Aaltonen
December 2014, Molecular genetics and genomics : MGG,
Iikki Donner, and Riku Katainen, and Tomas Tanskanen, and Eevi Kaasinen, and Mervi Aavikko, and Kristian Ovaska, and Miia Artama, and Eero Pukkala, and Lauri A Aaltonen
October 2014, Oncology reports,
Copied contents to your clipboard!